Study Objectives: To evaluate the short-term efficacy of acupuncture for the treatment of peri-menopausal insomnia (PMI). Methods: Design: A randomized, participant-blind, placebo-controlled trial consisted of the acupuncture group (n = 38) and placebo-acupuncture group (n = 38). Setting: A tertiary teaching and general hospital. Participants: 76 peri-menopausal women with insomnia disorder based on the International Classification of Sleep Disorders, Third Edition. Interventions: A 10-session of acupuncture at bilateral Shenshu (BL 23) and Ganshu (BL 18) with unilateral Qimen (LR 14) and Jingmen (GB 25) or Streitberger needles at the same acupoints was performed for over 3 weeks. Measurements: Pittsburgh Sleep Quality Index (PSQI) and Insomnia Severity Index (ISI) with over-night polysomnography (PSG) exam were completed at baseline and post-treatment. Results: After the treatments, the decrease from baseline in PSQI score was 8.03 points in acupuncture group and 1.29 points in placebo-acupuncture group. The change from baseline in ISI score was 11.35 points in acupuncture group and 2.87 points in placebo-acupuncture group. In PSG data, acupuncture significantly improved the sleep efficiency and total sleep time, associated with less wake after sleep onset and lower percent stage 1 after the treatment. No significant differences from baseline to post-treatment were found in placebo-acupuncture group. Conclusions: Acupuncture can contribute to a clinically relevant improvement in the short-term treatment of PMI, both subjectively and objectively. Clinical Trial Registration: Acupuncture for peri-menopause insomnia: a randomized controlled trial,
INTRODUCTION
Menopause, characterized by a marked decrease in the production of female sex hormones, is due to the decreased ovarian function. Women report many non-vasomotor symptoms across the menopausal transition, including sleep disturbances. 1 In the National Institutes of Health study, the occurrence of insomnia during menopause is up to 39%-47%, 2 whereas some other large population-based studies demonstrate 33%-55% of women aged 40-55 report insomnia symptoms. [2] [3] [4] [5] Beyond its prevalence, sleep disturbances in menopausal women have an adverse effect on life quality and occupational performance 6 and are associated with increased health care costs. 7 It is extremely crucial to care for the health of menopausal women because with long-term sleep disturbances, they will ultimately show comparatively poorer physiological and mental health and a deteriorating quality of life. 8 Hormone replacement therapy (HRT) and some other effective medications are considered as effective treatments for peri-menopausal insomnia (PMI). 9, 10 However, due to adverse effects, such as heart diseases 11 and drug dependence, 12 the medication use is restricted. Several studies have indicated that cognitive behavioral therapy for insomnia (CBT-I) produces significant improvements in sleep with well-sustained and no adverse outcomes, 13, 14 as well as for peri-menopausal insomnia. 15 However, this therapy is rarely used in Chinese patients largely due to the cultural congruence 16 and limited qualified therapists with high costs.
Acupuncture, as an important component of Traditional Chinese Medicine (TCM), has been widely used in China 17 and some western countries. 18 Nowadays, the clinical effect of acupuncture in treating insomnia is gaining increasing attention, although still controversial. 19, 20 Several studies have been performed to investigate the efficacy of electroacupuncture for primary insomnia and residual insomnia associated with major depressive disorder. 21, 22 Since the different opinions on acupuncture-electroacupuncture efficacy and its mechanisms on pain, [23] [24] [25] acupuncture might have different effects in insomniacs as well.
A systematic review of traditional needle acupuncture for insomnia indicated that manual acupuncture might be a promising treatment modality for insomnia, but due to the poor research design, the conclusion was unclear. 26 In a multi-center controlled trial, the ten-session of acupuncture plus self-care alleviated sleep and vasomotor symptoms (VMS) in post-menopausal women. 27 Likewise, Hachul H et al. reported that acupuncture could significantly improve insomnia in post-menopause women. 28 Unlike primary insomnia, PMI is accompanied by hypothalamic-pituitary-ovarian hormonal changes which may affect the sleep through homeostatic sleep drive and circadian rhythms related neuron-chemicals. 2, 29 According to the theory of TCM, the main pathological change in peri-menopausal women is yin deficiency in kidney and liver. Therefore, we chose acupoints based on disease differentiation and special acupoints combinations to nourish liver and kidney. Shenshu (BL 23) and Ganshu (BL 18) are adopted as the main points to nourish liver and kidney yin 30 and have been used to treat the patients with menopausal insomnia 31 and peri-menopausal syndrome. 32 To balance yin-yang, two paired Back-shu points and Front-mu acupoints, BL23 with LR14 and BL18 with GB25, were used.
Considering the efficacy of manual acupuncture in many areas and the lack of studies in PMI, 33 we conducted a randomized, placebo-controlled trial to assess the short-term efficacy of acupuncture in peri-menopausal women with insomnia.
METHODS

Study design
This was a randomized, single (participant)-blind, parallel, placebo-controlled trial performed according to CONSORT guideline 34 and the criteria of Standards for Reporting Interventions in Clinical Trials of Acupuncture guideline. 35 The study was approved by the Institutional Review Board of Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine (Shanghai, China).
Participants
Study participants were recruited from the same urban area (Shanghai, China) by newspaper and social media between 2015 and 2016. The study took place at the acupuncture clinic of Yueyang Hospital of Integrated Traditional Chinese and Western Medicine. All who wanted to participate in the study phoned the study coordinator and an initial clinical interview appointment was made.
The diagnosis of chronic insomnia was made with clinical interview together with sleep diaries according to International Classification of Sleep Disorders, Third Edition (ICSD-3). 36 Peri-menopause was defined as menstrual cycle irregularity (a change of 7 days or more in the menstrual cycle) or amenorrhea for no longer than 60 consecutive days, according to the recommendations from the Stages of Reproductive Aging Workshop. 37 The inclusion criteria were as follows: night sleep disturbance and associated daytime symptoms occurred at least three times per week for three months during peri-menopause, a total score higher than five on Pittsburgh Sleep Quality Index (PSQI) questionnaire, 38 and no experience on acupuncture.
To confirm that study participants met ICSD-3 criteria, semi-structured interview questionnaires were conducted in the clinical interview by an experienced clinician. The interview questionnaire included the cause/mainly problem/frequency/ consequence/current treatments of insomnia and other information about their sleep habits/sleep related behaviors/history of physical diseases/history of mental illness. Besides, all the potential participants completed a sleep diary for 14 days before the clinical interview to get the information about their typical sleep pattern.
Participants were excluded if they (1) were in menopause transition due to surgery, (2) took medications that were intended to treat insomnia within the last 2 weeks prior to the polysomnography (PSG) monitoring, (3) received hormones or hormonal contraceptives within the last month, (4) were diagnosed with psychiatric disorders according to Diagnostic and Statistical Manual of Mental Disorders (DSM-V), 39 (5) had a PSG-detected apnea-hypopnea index of 10 or greater or a periodic limb movement index with arousal of 15 or greater, 21 (6) had an infection close to the position of the specified acupoints, (7) had any serious physical illness, and (8) had participated in any clinical trial in the last 3 months.
Intervention
All the treatments in both groups were performed by one acupuncturist with 3 years of experience. The acupuncturist obtained a Master degree in Shanghai University of TCM and was a registered practitioner of TCM. All research assistants received a one-day training session to become more familiar with the treatment protocol.
Participants in acupuncture group were in lateral position for needling at bilateral Shenshu (BL 23) and Ganshu (BL 18) with unilateral Qimen (LR 14) and Jingmen (GB 25). We employed a style of Chinese acupuncture and chose Shenshu (BL 23) and Ganshu (BL 18) as main acupoints. 40 We also used the combination of Back-shu points (which were Shenshu [(BL 23)] and Ganshu [(BL 18)] in this study) and Front-mu points 41 (which were Qimen [(LR 14)] and Jingmen [(GB 25)] in this study) by expert opinions and our own clinical practice. Acupuncture needles were standard stainless steels, sterile, and disposable (0.25 × 40 mm in length; Jia Jian, China). They were inserted into the skin to a depth of 10-30 mm due to the fatty tissues at the site of the acupoints and manipulated manually until needling sensations reported by participants were obtained. The sensation referred to the soreness or heaviness or distention manifested during the process of needling. After that, needles were retained for further 20 minutes before removal. 42 In the placebo acupuncture group, we used a non-invasive placebo control, the Streitberger Placebo-needle. 43 It has been used in acupuncture trials for insomnia as placebo control 22 and has been proved to be served as a credible sham control in Chinese populations. 44 Acupoints were the same with acupuncture group. Participants in both groups were treated three times per week for 10 times by the same acupuncturist. They were informed about the acupuncture and placebo acupuncture as follows:"In this study, different types of acupuncture treatment will be compared. One type is the usual acupuncture, and the other is associated with positive outcomes in previous clinical studies." 45 
Measures
The PSQI is a 19-item self-report questionnaire used to measure general sleep quality. It evaluates seven domains in the past month: duration of sleep, sleep disturbance, sleep-onset latency, daytime dysfunction due to night sleep, sleep efficiency, need for medications to sleep, and overall sleep quality. 38 A total score higher than five indicates insufficient sleep quality. 46 The Insomnia Severity Index (ISI) questionnaire is used to measure the nighttime and daytime symptoms of insomnia with each seven items rated on a 0-to 4-point scale. 47 A composite score is obtained by summing up the seven ratings, with a score of 14 (total score ranges from 0-28) providing the best cutoff to optimize sensitivity and specificity. 47 All self-report questionnaires were presented in Chinese language. The Chinese versions of PSQI and ISI questionnaires have been proved to be reliable and valid 48, 49 and are widely used as main evaluation tools for insomniacs in clinic and study trials.
PSQI and ISI are subjective self-report questionnaires, whereas PSG consists of multiple quantitative parameters. In this study, PSG (NIHON KOHDEN, Japan) monitored nearly 8 hours starting at each participant's usual bedtime on the baseline and post-treatment visit. Sleep electroencephalogram was subdivided into 30-second epochs, and sleep stages were manually scored according to the American Academy of Sleep Medicine Manual for the Scoring of Sleep and Associated Events. 50 The parameters studied included the following: (1) sleep-onset latency (SOL; lights out to first epoch of any sleep, in minutes); (2) total sleep time (TST; in minutes); (3) wake after sleep onset (WASO; total recording time-SOL-TST, in minutes); (4) percent sleep efficiency (SE; TST/total recording time × 100%); (5) arousal index (ArI; number of arousals × 60/ TST); and (6) percent of TST in each stage (time in each stage/ TST × 100%).
Assessments
After a clinical interview and over-night PSG, participants were asked to fulfill the general information on the next day of PSG recording. The general information included sociodemographic data, caffeine and alcohol consumption, medical history, current use of medication, and a set of structured self-reported questionnaires. Within 3 days after the first PSG recording, participants received the initial acupuncture treatment. At the end of the 10-time-treatment, the participants were subjected to the second PSG recording no more than 2 days, along with fulfilling the same set of questionnaires. All the PSG scoring and questionnaires were assessed by one experienced PSG technologist who was blinded to group allocation.
The primary outcome of this study was the change in PSQI scores from baseline to post-treatment. Secondary outcomes consisted of (1) change in ISI scores and (2) changes in PSG sleep parameters including SOL, TST, WASO, SE, ArI, percent of stage N1, N2, N3, and stage R.
Adverse events (AEs) were assessed, managed by acupuncturist in each acupuncture session and on the second PSG recording night. Participants were asked as follows:"Have you felt any nausea or fainted during acupuncture? Have you found any pain inside the acupoints after picking out the needles? Or other discomforts after acupuncture that should be told us?" The acupuncturist also checked the site of needling before each treatment began. The vital signs were assessed at baseline and post-treatment PSG recording night.
Sample size
Our sample size estimation was based on change in PSQI scores. A clinically significant treatment effect was defined as at least 2.7-point difference in PSQI scores between acupuncture and placebo-acupuncture. 26 We expected that the active treatment would out-perform the placebo treatment by 3.5 point. A sample size of 34 in each group would have a power of 90% to detect a 3.5-point difference between the two groups at an alpha level of 0.05. Allowing a 10% attrition rate, we estimated that this study would require a sample size of 38 in each group.
Randomization and blinding
The group allocation list was generated by using SPSS 20.0 for IBM. The participants who met the criteria were randomly assigned to either acupuncture group or placebo-acupuncture group by an independent assistant. The treatment details were pre-packed in envelopes and were consecutively numbered according to the randomization schedule. Each participant was assigned to an order number and received an envelope with their name on it. The acupuncturist-ensured envelopes were still sealed before opening them.
Only the assistant and the acupuncturist were aware of the treatment allocation. Participants or other relevant researchers were kept blinded to the group allocation.
Statistical analysis
The analysis was based on the Per-Protocol Set population, with treatment-completed participants included. All data were entered twice by two researchers to ensure accuracy. Statistical analysis of data was performed using the SPSS 20.0 for IBM. Descriptive characteristics and baseline statistics were presented as mean ± standard deviation or median, interquartile range for continuous variables. We used unpaired t test or non-parametric test or χ 2 test to test group differences in baseline statistics. To examine the differential effect of acupuncture on sleep disturbances, we performed a repeated-measures ANOVA (General Linear Model) on most endpoints. p-Values of ≤.05 were considered statistically significant.
RESULTS
Participants characteristics
A total of 87 participants were recruited, of whom 11 were excluded because of screen failures. The remaining 76 participants were randomized to receive placebo-acupuncture (n = 38) or acupuncture (n = 38). One participant from each group discontinued due to their private condition. Thus, 74 participants completed the study (Figure 1) . Table 1 presents the demographic characteristics of the participants. Three participants had a habit of drinking coffee everyday. There was no significant difference in age between subjects in the acupuncture (52.0 ± 5.3) and placebo-acupuncture group (52.5 ± 5.9). Baseline clinical characteristics were balanced between the two groups ( Table 2, Table 3 ).
Efficacy
Participant-reported sleep assessments
There was an improvement in both PSQI and ISI scores after either acupuncture or placebo treatment ( 
PSG assessments
The results of PSG measurement are summarized in Table 3 18.91 ± 5.60%, p = .01) was reduced in the acupuncture group. However, no significant differences in the percentage of stages N2 and N3 were noted between the two groups (p > .05).
Adverse events
None of the remaining 74 participants withdrew due to AEs. None of the participants had acupuncture-related AEs in the acupuncture group. For the placebo-acupuncture group, 4 (10.8%) of 37 participants reported worsening of insomnia as adverse event. Other discomforts were not reported.
DISCUSSION
Previous studies have supported a significant effect of acupuncture on VMS reduction but it is still not clear whether the benefits on sleep are direct effects of acupuncture or secondary to the reduction of VMS. 51 To the best of our knowledge, this is the first study using the acupuncture and placebo-acupuncture to evaluate the short-term efficacy of improving sleep quality in PMI through subjective and objective measurements.
We found that PSQI and ISI scores decreased 8.03-and 11.35-point in the acupuncture group, respectively. Similarly, the improvements were also found in postmenopausal women. 27, 28, 51 Hachul and colleagues reported that there was a 3-point decline in the PSQI score after 10-session acupuncture treatment. 28 However, the details about acupoints and sham acupuncture group were not mentioned. Avis et al. demonstrated that acupuncture treatment could improve sleep quality detected by PSQI in peri-menopausal and post-menopausal women. 51 Borud et al. also showed that after acupuncture, post-menopausal women displayed a significant increase in the duration of night sleep. 27 In previous studies, the post-menopausal women who mainly suffered from VMS but not insomnia were recruited. In this study, we provided direct evidence for the benefits of acupuncture in treating PMI.
The most important aspect for the discrepancies might be the selection of acupoints. According to TCM principles, the selection for acupuncture points is mainly based on three strategies, i.e., acupoints of the corresponding meridian, experience points, and special acupoints combination. For corresponding meridian acupoints selection, it is mainly based on two principles: syndrome differentiation and disease differentiation. Syndrome differentiation, which means that patients are treated individually depending on their current conditions, may contribute to individualized selection of acupoints. In previous studies, acupoints used for insomnia treatment with high frequency were Baihui (GV-20), Sishencong (EX-HN1), Shenmen (He-7), Shenting (GV-24), and Sanyinjiao (SP-6) 52 which belong to experience acupoints for insomnia. For primary insomnia, emotional factors, overwork, and other factors are the main causes. They may cause the imbalance of YinYang and disharmony of Zang-Fu which would finally disturb the function of heart spirit. However, for insomnia related to peri-menopausal, yin deficiency of kidney and liver is the key pathological change. Given the unique hormonal changes in the context of PMI, we chose disease differentiation and special acupoints combination. From the disease differentiation perspective, BL 23 and BL18 are used to tonify liver and kidney. From the special acupoints combination perspective, two paired acupoints (BL23 with LR14 and BL18 with GB25) are called the combination of Back-shu points and Front-mu points. This kind of combination was first described in Suwen (素问) B.C. 403-A.D. 220. Back-shu points are located on the back yang, whereas front-mu points are located in the chest yin. This special acupoints combination is believed to improve the effect on balancing yin-yang and has been reported to be effective in many diseases. 41 Considering the inserting needles might trigger the body's responses whether they were superficial or deeper, we chose the non-invasive placebo intervention. In this study, PSQI score decreased almost 1.29-point in placebo-acupuncture group. The difference was modest and might not be clinically relevant. 26 Moreover, no significant differences in PSG parameters were found in placebo-acupuncture group. A previous study has shown that non-invasive placebo treatment resulted in an improvement of performance in participant-measured questionnaires. 22 A possible reason for this discrepancy may be that the participants we recruited had a positive attitude toward acupuncture treatment and this high expectation might over-optimize the responses. In this study, acupuncture effects on objective endpoints on sleep maintenance and architecture were observed. Compared with placebo-acupuncture, acupuncture group statistically showed improvements in TST and SE with ArI and WASO decreased. In respect of sleep architecture, less stage 1 sleep and greater stage R sleep in acupuncture group were found. Other study demonstrated that acupuncture intervention could improve sleep quality by increasing the percentage of slow wave sleep (SWS), 28 but in this study, there was no statistically difference in SWS perhaps for its normal range of proportion at the baseline. However, due to some limiting conditions, we only conducted one-night PSG assessment which would affect the accuracy of conclusion. Since the balance and stability of the sleep structure directly affect the feeling of sleep and sleep quality, in the future, acupuncture researchers may pay more attention to the recovery and stability of sleep structure. 53 To enhance patient compliance, the treatment was subdivided into 10 acupuncture sessions over 3 weeks. There were no clinically meaningful symptoms in adverse effects or vital sign changes between the two groups. The thrice-weekly course of acupuncture or placebo-acupuncture was well accepted by all participants. In conclusion, the 10-session acupuncture treatment increased PSQI and ISI scores and improved sleep quality.
Limitations
Our study has several limitations. PSG data were monitored for just one night at each time point. A consensus report on the research assessment of insomnia recommends that PSG is feasible to be conducted for one to three nights. 54 Averaging two nights for each study time point is a common choice. It is noteworthy that there is a discrepancy between the self-reported sleep-assessments and PSG findings. Although baseline mean PSG-derived SE was less than 85%, only a few participants had PSG-derived SOL of greater than 30 minutes, which may explain no clinical improvement of SOL after treatment. In addition, acupuncturist could not be blinded to treatment group and the measure of treatment fidelity has not been established. Although no significant adverse effects were observed, the next-day residual effects and daytime performance need to be further assessed.
CONCLUSIONS
This study provides evidence for the therapeutic potential of acupuncture in the treatment of PMI. We suggest that acupuncture represents a safe and useful non-pharmacologic intervention option for PMI.
